BRIEF published on 03/25/2026 at 15:16, 1 day 2 hours ago NANOBIOTIX denies takeover rumors Biotechnology Takeover NANOBIOTIX Rumors Nanoparticles
BRIEF published on 03/25/2026 at 15:16, 1 day 2 hours ago NANOBIOTIX Responds to Media Speculation on Takeover Intentions Biotechnology Nanotechnology Takeover Speculation NANOBIOTIX Public Statement
PRESS RELEASE published on 03/25/2026 at 15:11, 1 day 2 hours ago NANOBIOTIX Statement Regarding Recent Media Speculation Nanobiotix issues statement addressing media speculation on public take-over intentions, denying any such plans and highlighting factual inaccuracies in recent reports Media Speculation Statement NANOBIOTIX Public Take-over Factual Inaccuracies
BRIEF published on 03/12/2026 at 21:20, 13 days 20 hours ago Nanobiotix Announces Voting Rights and Share Capital Details Euronext Paris Share Capital Voting Rights Nasdaq NANOBIOTIX
PRESS RELEASE published on 03/12/2026 at 21:15, 13 days 20 hours ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital details as of February 28, 2026, on Euronext Paris and Nasdaq markets. Learn about their disruptive therapeutic approaches and global presence Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/25/2026 at 22:20, 1 month ago NANOBIOTIX Presents at Key Conferences in March Biotechnology Investor Conferences Cancer Treatments NANOBIOTIX Clinical Advances
BRIEF published on 02/17/2026 at 22:20, 1 month 8 days ago Nanobiotix Announces Updated Voting Rights and Share Capital Euronext Paris Voting Rights Shares Capital Financial Disclosure NANOBIOTIX
PRESS RELEASE published on 02/17/2026 at 22:15, 1 month 8 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. The biotech company is listed on Euronext Paris and Nasdaq, focusing on disruptive therapies Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/02/2026 at 09:44, 1 month 24 days ago Goldman Sachs reduces its stake in Nanobiotix Euronext Paris Goldman Sachs Threshold Crossing Transfer Of Shares NANOBIOTIX
BRIEF published on 01/26/2026 at 09:56, 2 months ago Goldman Sachs crosses thresholds in Nanobiotix Voting Rights Goldman Sachs Crossing Thresholds NANOBIOTIX Off-market Acquisition
Published on 03/26/2026 at 16:20, 1 hour 41 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 5 hours 1 minute ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 5 hours 1 minute ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 5 hours 2 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 17:51, 9 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/26/2026 at 17:45, 15 minutes ago CTS EVENTIM exceeds EUR 3 billion in revenue for the first time, sustaining profitable growth
Published on 03/26/2026 at 17:20, 40 minutes ago EQS-Adhoc: Leifheit Aktiengesellschaft: Board of Management and Supervisory Board propose to the Annual General Meeting a capital increase from the company’s own funds, followed by an ordinary capital reduction
Published on 03/26/2026 at 17:19, 41 minutes ago Haier Smart Home Reports Full-Year 2025 Results: Global Revenue Surpasses RMB 300 Billion for the First Time; Net Profit Reaches a Record Highs
Published on 03/26/2026 at 07:30, 10 hours 31 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 23 hours 29 minutes ago Strong investment performance and active roll-out of our strategy
